Based on our presence in the many countries and networks Hexaphoenix is representing a number of nationally and internationally renowned companies who develop and contract manufacture generic products from EUGMP plants including European and Indian manufacturing facilities. We thus offer a range of differentiated finished drug products as projects for In-Out Licensing or contract manufacturing services from our partner research and developments.
We have expertise covering a variety of therapeutic areas such as CNS, CVS, Oncology, Urology, Gynecology, Gastro-Entomology, Cardiology in different Pharmaceutical formulations such as oral Tablets, Capsules, Syrup, Injectable and external topical formulations. In addition to being the expert in Herbal and Natural Cosmeceutical solutions.
Hexaphoenix is committed towards Manufacturing and Marketing of pharmaceuticals products, following an integrated QUALTY MANAGEMENT SYSTEM (QMS) meet customer and regulatory requirements to ensure Quality, Safety and Efficacy of our products.
For further more detailed information on product opportunities and services, please contact us:
Strength: 100mg /200mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 75mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250mg /500mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 1.25mg /2.5mg/3.75mg/5mg/7.5mg/10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg/20mg/30mg/40mg/60mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD / ACTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 30mg/60mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 40/160mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 500mg/750mg/1000mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: Prochlorperazine | Tablet | 5mg
Prochlorperazine (OTC) | Buccal Tablet | 3mg
Prochlorperazine (Prescription Only) | Buccal Tablet | 3mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 10 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 7.5mg/5ml, 30mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5/10/20/25mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 375mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD / ACTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 250mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 800mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5mg / 7.5mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 5mg/5ml
Dosage: Syrup
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 30 mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 50/100mg
Dosage: Capsules
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 12.5/25/50/100mg
Dosage: Tablets
Approved Authority: UKMHRA Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: UK not available
Strength: 0.5mg / 0.75mg / 1.0mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg + 125mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg + 125mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 2mg
Dosage: ODT (Lingual) Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 8mg /16mg / 24mg /48mg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 0.5mg / ml
Dosage: Oral Solution
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 500 mg / 1000mg
Dosage: Granules in Sachet
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 1mg/5mg/10mg
Dosage: Film Coated Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 62.5 mcg
Dosage: Tablets
Approved Authority: EUGMP Approved
Dossiers Available: eCTD
Bioequivalence (BE/BA) study: Available
Market Availability: All market available, Ask More details for availability
Strength: 5 IU and 10 IU
Dosage: Injection
Approved Authority: WHO Prequalified and From EUGMP Approved Plant
Dossiers Available: Ready CTD
Bioequivalence (BE/BA) study: Not Required for Injection
Market Availability: Not available for Ghana, Tanzania, Vietnam, Sri Lanka.